Title : Etoricoxib versus naproxen in patients with rheumatoid arthritis: a prospective, randomized, comparator-controlled 121-week trial.

Pub. Date : 2007 Sep

PMID : 17697449






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND: Etoricoxib is a cyclooxygenase-2 (COX-2) selective inhibitor effective in the treatment of rheumatoid arthritis. Etoricoxib prostaglandin-endoperoxide synthase 2 Homo sapiens
2 BACKGROUND: Etoricoxib is a cyclooxygenase-2 (COX-2) selective inhibitor effective in the treatment of rheumatoid arthritis. Etoricoxib prostaglandin-endoperoxide synthase 2 Homo sapiens